Skip to main content

Immunic, Inc.

IMUX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001280776

No open-market purchases or sales by Immunic, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $130.6M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Immunic, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of IMUX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7367−6
Shares18.3M17.4M−820.4K (−4.5%)
Value$63.4M$55.1M−$8.24M (−13.0%)

New holders (11)

Institutions that held Immunic, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to IMUX in Q3 2022
InstitutionSharesValue% of portfolio
Gratus Capital LLC753,190$2.38M0.25%
Walleye Capital LLC104,150$329.0K0.01%
Parallax Volatility Advisers, L.P.50,715$160.0K0.00%
Jefferies Group LLC38,703$122.3K0.00%
Gsa Capital Partners LLP29,720$94.0K0.01%
Jacobs Levy Equity Management, Inc25,421$80.0K0.00%
Marshall Wace, LLP24,373$77.0K0.00%
Susquehanna Fundamental Investments, LLC17,673$56.0K0.00%
Denali Advisors LLC17,000$54.0K0.03%
China Universal Asset Management Co., Ltd.287$1.00K0.00%
Adirondack Retirement Specialists, Inc.2$00.00%

Sold out (17)

Institutions that held Immunic, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of IMUX in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Adage Capital Partners GP, L.L.C.600,900$2.08M
Citadel Advisors LLC496,554$1.72M
KCK Ltd.69,704$242.0K
Jane Street Group, LLC69,345$241.0K
Ikarian Capital, LLC61,500$214.0K
Endurant Capital Management LP30,591$106.0K
Altshuler Shaham Ltd22,200$77.0K
XTX Topco Ltd19,972$69.0K
Boothbay Fund Management, LLC17,831$62.0K
Delphia (USA) Inc.13,181$46.0K
Corton Capital Inc.12,142$42.0K
LMR Partners LLP10,000$35.0K
Barclays PLC400$1.00K
New York State Common Retirement Fund156$1.00K
Credit Suisse AG10$0
CWM, LLC12$0
Point72 Hong Kong Ltd58$0